It is thus possible that the level of TRIM59-IFT80 will be affected more in breast cancer cells, although it is not clear if and how the complementarity to intronic sequences might affect the splicing of TRIM59-IFT80 and thus its level. This evidence concerns the gene TRIM59 and breast cancer.